145 related articles for article (PubMed ID: 29120277)
1. Real-World Effectiveness of Clozapine for Borderline Personality Disorder: Results From a 2-Year Mirror-Image Study.
Rohde C; Polcwiartek C; Correll CU; Nielsen J
J Pers Disord; 2018 Dec; 32(6):823-837. PubMed ID: 29120277
[TBL] [Abstract][Full Text] [Related]
2. Real-world effectiveness of clozapine for intellectual disability: Results from a mirror-image and a reverse-mirror-image study.
Rohde C; Hilker R; Siskind D; Nielsen J
J Psychopharmacol; 2018 Nov; 32(11):1197-1203. PubMed ID: 29944071
[TBL] [Abstract][Full Text] [Related]
3. Clozapine in borderline personality disorder: a review of the evidence.
Beri A; Boydell J
Ann Clin Psychiatry; 2014 May; 26(2):139-44. PubMed ID: 24812651
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of the role of clozapine for severe borderline personality disorder.
Han J; Allison S; Looi JCL; Chan SKW; Bastiampillai T
Psychopharmacology (Berl); 2023 Oct; 240(10):2015-2031. PubMed ID: 37572113
[TBL] [Abstract][Full Text] [Related]
5. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder.
Benedetti F; Sforzini L; Colombo C; Maffei C; Smeraldi E
J Clin Psychiatry; 1998 Mar; 59(3):103-7. PubMed ID: 9541151
[TBL] [Abstract][Full Text] [Related]
6. Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study.
Nielsen J; Nielsen RE; Correll CU
J Clin Psychopharmacol; 2012 Oct; 32(5):678-83. PubMed ID: 22926603
[TBL] [Abstract][Full Text] [Related]
7. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study.
Nielsen J; Kane JM; Correll CU
Bipolar Disord; 2012 Dec; 14(8):863-9. PubMed ID: 23107278
[TBL] [Abstract][Full Text] [Related]
8. Association of pharmacological treatments and real-world outcomes in borderline personality disorder.
Lieslehto J; Tiihonen J; Lähteenvuo M; Mittendorfer-Rutz E; Tanskanen A; Taipale H
Acta Psychiatr Scand; 2023 Jun; 147(6):603-613. PubMed ID: 37094828
[TBL] [Abstract][Full Text] [Related]
9. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.
Chengappa KN; Ebeling T; Kang JS; Levine J; Parepally H
J Clin Psychiatry; 1999 Jul; 60(7):477-84. PubMed ID: 10453803
[TBL] [Abstract][Full Text] [Related]
10. A case series of clozapine for borderline personality disorder.
Frogley C; Anagnostakis K; Mitchell S; Mason F; Taylor D; Dickens G; Picchioni MM
Ann Clin Psychiatry; 2013 May; 25(2):125-34. PubMed ID: 23638443
[TBL] [Abstract][Full Text] [Related]
11. Clozapine treatment of a borderline personality disorder with severe self-mutilating behaviours.
Ferreri MM; Loze JY; Rouillon F; Limosin F
Eur Psychiatry; 2004 May; 19(3):177-8. PubMed ID: 15158928
[No Abstract] [Full Text] [Related]
12. Emerging evidence for the use of atypical antipsychotics in borderline personality disorder.
Grootens KP; Verkes RJ
Pharmacopsychiatry; 2005 Jan; 38(1):20-3. PubMed ID: 15706462
[TBL] [Abstract][Full Text] [Related]
13. Medication for borderline personality disorder: a survey at a secure hospital.
Haw C; Stubbs J
Int J Psychiatry Clin Pract; 2011 Nov; 15(4):280-5. PubMed ID: 22122000
[TBL] [Abstract][Full Text] [Related]
14. Clozapine treatment of borderline patients: a preliminary study.
Frankenburg FR; Zanarini MC
Compr Psychiatry; 1993; 34(6):402-5. PubMed ID: 8131384
[TBL] [Abstract][Full Text] [Related]
15. Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine.
Steinert T; Schmidt-Michel PO; Kaschka WP
Pharmacopsychiatry; 1996 May; 29(3):111-4. PubMed ID: 8738316
[TBL] [Abstract][Full Text] [Related]
16. Differential effectiveness of antipsychotics in borderline personality disorder: meta-analyses of placebo-controlled, randomized clinical trials on symptomatic outcome domains.
Ingenhoven TJ; Duivenvoorden HJ
J Clin Psychopharmacol; 2011 Aug; 31(4):489-96. PubMed ID: 21694626
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacotherapy effectiveness for some symptoms of borderline personality disorder].
Benjaminsen S
Ugeskr Laeger; 2014 Sep; 176(36):. PubMed ID: 25293847
[TBL] [Abstract][Full Text] [Related]
18. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain.
Pascual JC; Martín-Blanco A; Soler J
CNS Drugs; 2021 Sep; 35(9):1023-1032. PubMed ID: 34370282
[TBL] [Abstract][Full Text] [Related]
19. Effect of Clozapine vs Other Second-Generation Antipsychotics on Hospitalization and Seclusion: A Retrospective Mirror-Image Study in a Japanese Public Psychiatric Hospital.
Misawa F; Suzuki T; Fujii Y
J Clin Psychopharmacol; 2017 Dec; 37(6):664-668. PubMed ID: 29045304
[TBL] [Abstract][Full Text] [Related]
20. Sublingual Oxytocin With Clozapine in a Patient With Persisting Psychotic Symptoms, Suicidal Thinking With Self-Harm.
Garakani A; Buono FD; Marotta RF
J Clin Psychopharmacol; 2020; 40(5):507-509. PubMed ID: 32701906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
